# Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674 (Cilofexor), and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics

> **NCT02654002** · PHASE1 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 120 (actual)

## Conditions studied

- Nonalcoholic Steatohepatitis (NASH)

## Interventions

- **DRUG:** Cilofexor
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02654002
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-20
- **Primary completion:** 2016-07-14
- **Final completion:** 2016-07-14
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2020-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02654002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02654002, "Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674 (Cilofexor), and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02654002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*